Chapter

An Applied Context for Personalized Medicine in Psychiatry

Alan F. Schatzberg

in Integrative Neuroscience and Personalized Medicine

Published in print December 2010 | ISBN: 9780195393804
Published online January 2011 | e-ISBN: 9780199863495 | DOI: http://dx.doi.org/10.1093/acprof:oso/9780195393804.003.0002
An Applied Context for Personalized Medicine in Psychiatry

Show Summary Details

Preview

This chapter reviews a number of early hypotheses about the role of neurotransmitters in depression. These hypotheses had some potential, but never had the impact one might have hoped for in the effort to shed light on the problems faced in personalized medicine in psychiatry. Psychiatry is hampered by its inherent inability to physically access the brain. Biopsies are not routinely performed to study illnesses such as depression, and, until recently, imaging the central nervous system was at best crude and at times painful for the patient. Recent advances in understanding genetics and depression, as well as results from brain imaging studies, provide opportunities for developing more targeted tests that hopefully are less affected by extraneous events. Still, the earlier experiences do provide some context, and lessons that can be used to develop more effectively personalized medicine for psychiatry.

Keywords: depression; neurotransmitters; personalized medicine; psychiatry; biopsy; genetics

Chapter.  4159 words. 

Subjects: Neuroscience

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.